365 related articles for article (PubMed ID: 27258330)
21. Identification of novel antibacterial peptides by chemoinformatics and machine learning.
Fjell CD; Jenssen H; Hilpert K; Cheung WA; Panté N; Hancock RE; Cherkasov A
J Med Chem; 2009 Apr; 52(7):2006-15. PubMed ID: 19296598
[TBL] [Abstract][Full Text] [Related]
22. Rational Evolution of Antimicrobial Peptides Containing Unnatural Amino Acids to Combat Burn Wound Infections.
Xiong M; Chen M; Zhang J
Chem Biol Drug Des; 2016 Sep; 88(3):404-10. PubMed ID: 27062533
[TBL] [Abstract][Full Text] [Related]
23. Influence of the Multivalency of Ultrashort Arg-Trp-Based Antimicrobial Peptides (AMP) on Their Antibacterial Activity.
Hoffknecht BC; Worm DJ; Bobersky S; Prochnow P; Bandow JE; Metzler-Nolte N
ChemMedChem; 2015 Sep; 10(9):1564-9. PubMed ID: 26149664
[TBL] [Abstract][Full Text] [Related]
24. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms.
Dosler S; Mataraci E
Peptides; 2013 Nov; 49():53-8. PubMed ID: 23988790
[TBL] [Abstract][Full Text] [Related]
25. Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.
Han HM; Gopal R; Park Y
Amino Acids; 2016 Feb; 48(2):505-22. PubMed ID: 26450121
[TBL] [Abstract][Full Text] [Related]
26. A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice.
Lee JK; Park SC; Hahm KS; Park Y
Biomaterials; 2014 Jan; 35(3):1025-39. PubMed ID: 24176194
[TBL] [Abstract][Full Text] [Related]
27. Synthetic membrane-targeted antibiotics.
Vooturi SK; Firestine SM
Curr Med Chem; 2010; 17(21):2292-300. PubMed ID: 20459377
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids.
Hicks RP
Bioorg Med Chem; 2016 Sep; 24(18):4056-4065. PubMed ID: 27387357
[TBL] [Abstract][Full Text] [Related]
29. Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa.
Pasupuleti M; Chalupka A; Mörgelin M; Schmidtchen A; Malmsten M
Biochim Biophys Acta; 2009 Aug; 1790(8):800-8. PubMed ID: 19345721
[TBL] [Abstract][Full Text] [Related]
30. A New Synthetic Peptide with In vitro Antibacterial Potential Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).
Prada YA; Guzmán F; Rondón P; Escobar P; Ortíz C; Sierra DA; Torres R; Mejía-Ospino E
Probiotics Antimicrob Proteins; 2016 Sep; 8(3):134-40. PubMed ID: 27301970
[TBL] [Abstract][Full Text] [Related]
31. Functional structure and antimicrobial activity of persulcatusin, an antimicrobial peptide from the hard tick Ixodes persulcatus.
Miyoshi N; Saito T; Ohmura T; Kuroda K; Suita K; Ihara K; Isogai E
Parasit Vectors; 2016 Feb; 9():85. PubMed ID: 26873587
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides.
Kubicek-Sutherland JZ; Lofton H; Vestergaard M; Hjort K; Ingmer H; Andersson DI
J Antimicrob Chemother; 2017 Jan; 72(1):115-127. PubMed ID: 27650186
[TBL] [Abstract][Full Text] [Related]
33. Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.
Zhu X; Ma Z; Wang J; Chou S; Shan A
PLoS One; 2014; 9(12):e114605. PubMed ID: 25494332
[TBL] [Abstract][Full Text] [Related]
34. Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.
Grafskaia EN; Nadezhdin KD; Talyzina IA; Polina NF; Podgorny OV; Pavlova ER; Bashkirov PV; Kharlampieva DD; Bobrovsky PA; Latsis IA; Manuvera VA; Babenko VV; Trukhan VM; Arseniev AS; Klinov DV; Lazarev VN
Eur J Med Chem; 2019 Oct; 180():143-153. PubMed ID: 31302447
[TBL] [Abstract][Full Text] [Related]
35. Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa.
Stach M; Siriwardena TN; Köhler T; van Delden C; Darbre T; Reymond JL
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12827-31. PubMed ID: 25346278
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial Activity of a Cationic Antimicrobial Peptide against Multidrug-Resistant Gram-Negative Clinical Isolates and Their Potential Molecular Targets.
Rivera-Sánchez SP; Agudelo-Góngora HA; Oñate-Garzón J; Flórez-Elvira LJ; Correa A; Londoño PA; Londoño-Mosquera JD; Aragón-Muriel A; Polo-Cerón D; Ocampo-Ibáñez ID
Molecules; 2020 Oct; 25(21):. PubMed ID: 33142969
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial evaluation of structurally amphipathic, membrane active small cationic peptidomimetics: synthesized by incorporating 3-amino benzoic acid as peptidomimetic element.
Lohan S; Cameotra SS; Bisht GS
Eur J Med Chem; 2014 Aug; 83():102-15. PubMed ID: 24953028
[TBL] [Abstract][Full Text] [Related]
38. In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms.
Flamm RK; Rhomberg PR; Simpson KM; Farrell DJ; Sader HS; Jones RN
Antimicrob Agents Chemother; 2015 Mar; 59(3):1751-4. PubMed ID: 25583717
[TBL] [Abstract][Full Text] [Related]
39. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
Hilpert K; Fjell CD; Cherkasov A
Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
[TBL] [Abstract][Full Text] [Related]
40. Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior.
Saint Jean KD; Henderson KD; Chrom CL; Abiuso LE; Renn LM; Caputo GA
Probiotics Antimicrob Proteins; 2018 Sep; 10(3):408-419. PubMed ID: 29103131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
